Skip to main content

Bumrungrad Hospital Public Company Limited (BUHPF)

New York Stock Exchange Healthcare Medical - Care FacilitiesView data quality →
66.5Fair

ValueMarkers Composite Index

Top 96%#1,800 of 44,707
Undervalued

54% below intrinsic value ($0)

UndervaluedFair ValueOvervalued
Piotroski
4/9
Neutral
Beneish
-2.86
Low Risk
Altman
3.58
Safe
DCF Value
$0
Undervalued
ROIC
22.0%
Strong
P/E
18.3
Fair
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Bumrungrad Hospital Public Company Limited (BUHPF) — VMCI valuation read

The headline on Bumrungrad Hospital Public Company Limited (BUHPF) is a 67/100 VMCI score, set against a Healthcare sector median of 50. That 17-point above-median read reflects the five-pillar weighting and, for a mid-cap name, suggests a relative-value tailwind is in the data.

BUHPF insider activity report: 0 buys, 0 sells filed via Form 4 over the past 30 days. The next datable items are the 10-Q schedule and any 8-K-triggering events; both feed the VMCI Integrity pillar more than the price tape.

**Investor frame.** BUHPF trades at 27.0x earnings, 50% above the Healthcare median of 18.0x sets the value side. ROIC of 15.0% sits 5.0pp above the Healthcare median (10.0%) sets the quality side. Net debt to EBITDA of 1.3x leaves covenant headroom sets the risk side, the three lines a value buyer reads first on BUHPF.

BUHPF fell 1.6% over the trailing 7 days, with a -20.2% read on a 30-day basis.

Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. The company offers diagnostic, therapeutic, and intensive care facilities in a medical center. Its outpatient clinics/centers include allergy, arrhythmia, behavioral health, breastfeeding, breast care, children, dental, diabetes, diagnostic, dialysis, digestive disease, emergency, eye, fertility and IVF, health screening, hearing and balance, heart valve, cancer, hyperbaric oxygen therapy, hypertension, joint replacement, liver, memory, men, nephrology, neuroscience, new life healthy aging, orthopedic, Parkinson's disease and movement disorders, perinatal, physical therapy and rehabilitation, plastic surgery, pulmonary, refractive surgery, robotic scoliosis and surgery, skin, sleep lab, spine, sports medicine and lifestyle, surgical, travel medicine, urology, vitalife, and women's, as well as ear, nose, and throat centers. In addition, the company is involved in the real estate assets holding activities; provision of clinical research services; distribution of pharmaceutical and medical goods in specialized stores; operation of personnel development and training center for healthcare services; and patient referral service business. It operates 580 beds and approximately 56 clinics/centers. The company was founded in 1980 and is headquartered in Bangkok, Thailand.

CEO: Artirat CharukitpipatTHwww.bumrungrad.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in BUHPF’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.